about
Mechanisms of drug resistance in kinases.Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond.Fabrication of a bowl-shaped silver cavity substrate for SERS-based immunoassay.Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms.Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanomaMeasurement of Soluble Biomarkers by Flow Cytometry.Multiparameter flow cytometry for discovery of disease mechanisms in rheumatic diseases.
P2860
Q27692567-CADA0537-AE4A-4B9C-B765-19A53B592376Q30432926-77CF6120-1272-4386-B033-DA0D1D379D76Q34615980-A0E67316-5576-488E-9DDC-603C3FE850D1Q35670126-517A1205-682F-4B23-81E4-4BDABDF0BB43Q36110293-6A49E914-EA6C-44A7-AA48-EF19DC4720F1Q37155342-C4CDD201-E70B-4544-8EDF-6EB006896F4EQ40107170-603850AC-FF46-435A-8545-BB0DD8E6A0AC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New technologies for autoimmune disease monitoring
@en
New technologies for autoimmune disease monitoring.
@nl
type
label
New technologies for autoimmune disease monitoring
@en
New technologies for autoimmune disease monitoring.
@nl
prefLabel
New technologies for autoimmune disease monitoring
@en
New technologies for autoimmune disease monitoring.
@nl
P2093
P2860
P1476
New technologies for autoimmune disease monitoring
@en
P2093
Charles G Fathman
Garry P Nolan
Holden T Maecker
P2860
P304
P356
10.1097/MED.0B013E32833ADA91
P577
2010-08-01T00:00:00Z